How Trump is remaking US public health, with NY Times reporter Apoorva Mandavilli
Feb 8, 2025
auto_awesome
Apoorva Mandavilli, a New York Times science and global health reporter, discusses the dramatic shifts in U.S. public health policy during the Trump administration. She delves into the controversial nomination of RFK Jr. and the deepening vaccine skepticism in America. Mandavilli explores the implications of withdrawing from the WHO and the challenges of public trust in health messaging. With rising concerns about future pandemics, she highlights a crucial need for reform in health institutions like the CDC and NIH, questioning whether these changes are corrections or risks.
The Trump administration's initiatives, including slashing funding and altering institutions like the CDC and FDA, could drastically reshape U.S. public health policy and its global implications.
RFK Jr.'s controversial views on vaccines present significant challenges to public trust in health initiatives and could undermine vaccination efforts amid rising chronic disease rates.
Deep dives
Potential Implications of Trump’s Health Care Policy
The Trump administration's approach to health care indicates significant shifts in funding and policy that could affect public health both domestically and globally. Key changes include slashing government spending and revamping institutions like the CDC, NIH, and FDA. The withdrawal from the World Health Organization is particularly concerning, as it removes a crucial entity that provides health guidelines and drug approval support for many countries, including the U.S. The confirmation of RFK Jr. as head of Health and Human Services adds further uncertainty, given his controversial views that could influence public trust and scientific integrity.
The Role of Vaccines in Public Health Debate
RFK Jr.'s history of vaccine skepticism presents challenges in addressing public health initiatives and maintaining trust in vaccination programs. During Senate hearings, he reiterated unfounded claims linking vaccines to autism while conflicting perspectives from senators highlighted the divide in the scientific community regarding vaccine safety. While he slightly moderated some statements, his overall stance suggests potential risks in undercutting support for established vaccination practices. The ongoing debate reflects a broader societal skepticism towards vaccines, which is exacerbated by polarized political discourse.
Challenges in Addressing Chronic Diseases
The U.S. faces a growing epidemic of chronic diseases, particularly among children, reflecting deeper issues in the healthcare system. RFK Jr. correctly identifies the rising rates of obesity and chronic illness, but often misstates statistics, which undermines the argument for necessary reforms. This growing health crisis stands in stark contrast to trends in other developed countries, where chronic disease rates are decreasing. Concerns regarding preventative care versus treatment highlight a critical area for improvement in U.S. health policy.
Concerns Over Potential Pandemics and Health Response
The rise of bird flu cases in the U.S. represents an urgent public health challenge that requires comprehensive monitoring and response strategies. Current surveillance has been criticized for being inadequate, leaving the country vulnerable to outbreaks that could have significant consequences. Experts warn that the politicization of health policies and public distrust may hinder effective responses to potential pandemics. The situation echoes past challenges faced during COVID-19, underscoring the need for robust frameworks to manage emerging health threats.
In President Trump’s short time in office, he’s already made sweeping changes to US public health policy—from RFK Jr.’s nomination to lead the health department to withdrawing the US from the World Health Organization. On the GZERO World Podcast, New York Times science and global health reporter Apoorva Mandavilli joins Ian Bremmer for an in-depth look at health policy in the Trump administration, and what it could mean, not just for the US, but for the rest of the world. President Trump has made it clear: he wants to slash government spending and remake institutions like the CDC, NIH, and FDA. But are those plans a much-needed correction to an overly bureaucratic system or prescription for the next pandemic?
What do we need to know about bird flu and changes to USAID? Bremmer and Mandavilli discuss RFK Jr.’s influence in Trump’s second term and what the future of health and medical policy in America could look like.